About City of Hope

City of Hope is an independent biomedical research and treatment organization for cancer, diabetes, and other life-threatening diseases.

Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and their health care partners by providing access to City of Hope’s specialized cancer expertise.

A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report and received Magnet Recognition from the American Nurses Credentialing Center. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.

City of Hope’s commitment to Diversity, Equity, and Inclusion

We believe diversity, equity and inclusion is key in serving our mission to provide compassionate patient care, drive innovative discovery, and advance vital education focused on eliminating cancer and diabetes in all our communities. Our commitment to Diversity, Equity and Inclusion ensures we bring the full range of skills, perspectives, cultural backgrounds, and experiences to our work -- and that our teams align with the people we serve to build trust and understanding. We are dedicated to fostering a community that embraces diversity - in ideas, backgrounds, and perspectives; this is reflected in our work and represented in our people.

Position Summary

A Postdoctoral Fellowship opportunity is immediately available for the highly motivated individual in the laboratory of Dr. Wendong Huang at the Beckman Research Institute of City of Hope, a prestigious NCI-designated Comprehensive Cancer Center.

The Wendong Huang lab uses genetically engineered mouse models and molecular pharmacology tools to identify novel signaling pathways in metabolic regulation and provide innovative targets for drug discovery. The lab primarily focuses on bile acids, bile acid receptors, and bile acid-gut microbiota crosstalk as metabolic mediators in regulating normal physiology and pathogenesis. The lab's second research focus is identifying and developing novel drug candidates, including those from natural products and other sources, to treat diabetes and cancer.

The Wendong Huang lab’s current research projects focus on:

• Identification of novel signaling molecules and pathways in regulating metabolism, diabetes and cancer
• Small molecules and RNA targeted therapy for diabetes and cancer
• Mechanisms underlying bariatric surgery and diabetes therapy

Basic education, experience and skills required for consideration:

• PhD or M.D.

Additional Information:

As a condition of employment, City of Hope requires staff to comply with all state and federal vaccination mandates.

• For more information on Dr. Huang please visit here